|
Nihon Parkerizing Co., Ltd. (4095.t) DCF -Bewertung |
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Nihon Parkerizing Co., Ltd. (4095.T) Bundle
Unabhängig davon, ob Sie ein Investor oder ein Analyst sind, ist dieser (4095T) DCF-Taschenrechner Ihre Anlaufstelle für eine genaue Bewertung. Mit echten Daten von Nihon Parkerizing Co., Ltd., können Sie Prognosen anpassen und die Auswirkungen sofort beobachten.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 119,028.0 | 99,918.0 | 117,752.0 | 119,177.0 | 125,085.0 | 127,574.5 | 130,113.6 | 132,703.2 | 135,344.4 | 138,038.1 |
| Revenue Growth, % | 0 | -16.06 | 17.85 | 1.21 | 4.96 | 1.99 | 1.99 | 1.99 | 1.99 | 1.99 |
| EBITDA | 19,119.0 | 16,303.0 | 19,283.0 | 18,596.0 | 27,192.0 | 21,967.7 | 22,404.9 | 22,850.8 | 23,305.6 | 23,769.5 |
| EBITDA, % | 16.06 | 16.32 | 16.38 | 15.6 | 21.74 | 17.22 | 17.22 | 17.22 | 17.22 | 17.22 |
| Depreciation | 6,516.0 | 5,622.0 | 5,912.0 | 5,927.0 | 6,244.0 | 6,656.0 | 6,788.5 | 6,923.6 | 7,061.4 | 7,201.9 |
| Depreciation, % | 5.47 | 5.63 | 5.02 | 4.97 | 4.99 | 5.22 | 5.22 | 5.22 | 5.22 | 5.22 |
| EBIT | 12,603.0 | 10,681.0 | 13,371.0 | 12,669.0 | 20,948.0 | 15,311.7 | 15,616.4 | 15,927.2 | 16,244.2 | 16,567.5 |
| EBIT, % | 10.59 | 10.69 | 11.36 | 10.63 | 16.75 | 12 | 12 | 12 | 12 | 12 |
| Total Cash | 62,668.0 | 67,155.0 | 75,820.0 | 76,891.0 | 90,621.0 | 81,957.8 | 83,589.0 | 85,252.6 | 86,949.4 | 88,679.9 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 34,960.0 | 35,599.0 | 37,444.0 | 37,247.0 | 41,221.0 | 41,080.6 | 41,898.2 | 42,732.1 | 43,582.6 | 44,450.0 |
| Account Receivables, % | 29.37 | 35.63 | 31.8 | 31.25 | 32.95 | 32.2 | 32.2 | 32.2 | 32.2 | 32.2 |
| Inventories | 9,789.0 | 9,354.0 | 10,046.0 | 11,548.0 | 11,054.0 | 11,390.9 | 11,617.7 | 11,848.9 | 12,084.7 | 12,325.2 |
| Inventories, % | 8.22 | 9.36 | 8.53 | 9.69 | 8.84 | 8.93 | 8.93 | 8.93 | 8.93 | 8.93 |
| Accounts Payable | 18,473.0 | 17,028.0 | 17,200.0 | 17,454.0 | 19,580.0 | 19,765.8 | 20,159.2 | 20,560.4 | 20,969.6 | 21,387.0 |
| Accounts Payable, % | 15.52 | 17.04 | 14.61 | 14.65 | 15.65 | 15.49 | 15.49 | 15.49 | 15.49 | 15.49 |
| Capital Expenditure | -9,171.0 | -4,908.0 | -4,232.0 | -9,607.0 | -7,422.0 | -7,706.9 | -7,860.3 | -8,016.8 | -8,176.3 | -8,339.1 |
| Capital Expenditure, % | -7.7 | -4.91 | -3.59 | -8.06 | -5.93 | -6.04 | -6.04 | -6.04 | -6.04 | -6.04 |
| Tax Rate, % | 36.98 | 36.98 | 36.98 | 36.98 | 36.98 | 36.98 | 36.98 | 36.98 | 36.98 | 36.98 |
| EBITAT | 7,653.3 | 6,487.6 | 7,633.6 | 7,598.5 | 13,202.2 | 9,234.7 | 9,418.5 | 9,605.9 | 9,797.1 | 9,992.1 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -21,277.7 | 5,552.6 | 6,948.6 | 2,867.5 | 10,670.2 | 8,173.0 | 7,695.7 | 7,848.9 | 8,005.1 | 8,164.4 |
| WACC, % | 5.02 | 5.02 | 5.02 | 5.02 | 5.02 | 5.02 | 5.02 | 5.02 | 5.02 | 5.02 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 34,506.2 | |||||||||
| Long Term Growth Rate, % | 0.50 | |||||||||
| Free cash flow (T + 1) | 8,205 | |||||||||
| Terminal Value | 181,458 | |||||||||
| Present Terminal Value | 142,029 | |||||||||
| Enterprise Value | 176,535 | |||||||||
| Net Debt | -89,481 | |||||||||
| Equity Value | 266,016 | |||||||||
| Diluted Shares Outstanding, MM | 115 | |||||||||
| Equity Value Per Share | 2,307.02 |
What You Will Receive
- Accurate 4095T Financials: Access to historical and projected data for precise valuations.
- Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditure parameters.
- Real-Time Calculations: Intrinsic value and NPV are automatically computed.
- Scenario Analysis: Explore various scenarios to assess Nihon Parkerizing’s future performance.
- User-Friendly Interface: Designed for professionals while remaining easy to use for newcomers.
Key Features
- Comprehensive Historical Data: Nihon Parkerizing Co., Ltd.'s (4095T) past financial statements and pre-filled projections.
- Customizable Inputs: Modify parameters such as WACC, tax rates, revenue growth, and EBITDA margins.
- Real-Time Results: Instantly view the recalculated intrinsic value of Nihon Parkerizing Co., Ltd. (4095T).
- Insightful Visuals: Dashboard graphs present valuation results and essential metrics at a glance.
- Designed for Precision: A reliable tool tailored for analysts, investors, and financial professionals.
How It Works
- Step 1: Download the Excel file for Nihon Parkerizing Co., Ltd. (4095T).
- Step 2: Examine the pre-filled financial data and forecasts for Nihon Parkerizing.
- Step 3: Adjust key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model update in real-time as you modify your assumptions.
- Step 5: Review the results and leverage the outputs for your investment decisions.
Why Select the Nihon Parkerizing Co., Ltd. Calculator?
- Save Time: Skip the hassle of building a DCF model from scratch – it’s instantly accessible.
- Enhance Accuracy: Dependable financial data and formulas minimize valuation errors.
- Completely Customizable: Adjust the model to suit your specific assumptions and forecasts.
- Simple to Understand: Intuitive charts and outputs facilitate easy result analysis.
- Preferred by Professionals: Crafted for those who prioritize precision and functionality.
Who Should Consider This Product?
- Investors: Evaluate Nihon Parkerizing Co., Ltd.'s (4095T) worth before making investment decisions.
- CFOs and Financial Analysts: Enhance the efficiency of valuation methods and assess future forecasts.
- Startup Founders: Discover how established firms like Nihon Parkerizing Co., Ltd. (4095T) are appraised.
- Consultants: Provide expert valuation assessments for your clients.
- Students and Educators: Utilize actual market data to learn and teach valuation strategies.
What the Template Includes
- Preloaded 4095T Data: Historical and projected financial information, encompassing revenue, EBIT, and capital expenditures.
- DCF and WACC Models: Advanced sheets for calculating intrinsic value and Weighted Average Cost of Capital.
- Editable Inputs: Yellow-highlighted cells for modifying revenue growth, tax rates, and discount rates.
- Financial Statements: Detailed annual and quarterly financials for comprehensive analysis.
- Key Ratios: Profitability, leverage, and efficiency ratios to assess performance.
- Dashboard and Charts: Visual representations of valuation results and assumptions.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.